Contact the Editorial Team

Editorial correspondence

Avenger Peptides welcomes correspondence on the research record: a citation we have quoted inaccurately, a regulatory status that has changed, or a peer-reviewed study about BPC-157, TB-500, GHK-Cu, or KPV that belongs on the references page. Corrections that improve accuracy are the most useful messages we receive, and they are read carefully.

The most actionable notes specify three things: the page in question, the exact passage, and the supporting citation — a DOI or PubMed ID wherever possible. That lets us verify a proposed change against the source efficiently.

Editorial mailbox: editors@avengerpeptides.com

What this site cannot do

So that no message goes unanswered for the wrong reason, here is what falls outside what this site can help with. Avenger Peptides is a literature digest, not a clinic or a vendor, so we cannot:

• Advise on, recommend, or comment on human use of any peptide discussed here.
• Suggest a dose, schedule, or route of administration for any individual.
• Diagnose a condition or assess whether a research finding applies to a specific person.
• Sell, source, recommend, or help locate any compound from any supplier.
• Respond to questions from athletes subject to anti-doping rules about using these compounds, given that several are prohibited in sport.

Readers looking for clinical guidance should consult a licensed clinician in their own jurisdiction. Responses to editorial correspondence are not guaranteed and may be delayed; the mailbox is monitored periodically.